Insmed (INSM) Operating Leases (2019 - 2026)

Insmed's Operating Leases history runs 8 years deep, the most recent figure standing at $9.8 million for Q1 2026.

• In Q1 2026, Operating Leases rose 16.0% year-over-year to $9.8 million; the TTM figure through Mar 2026 stood at $9.8 million (up 16.0% YoY), while the FY2025 annual figure was $12.2 million, up 33.6% from the prior year.
• Operating Leases was $9.8 million for Q1 2026 at Insmed, down from $12.2 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $19.9 million in Q1 2022 to a low of $7.6 million in Q3 2025.
• Historically, Operating Leases has averaged $12.4 million across 5 years, with a median of $12.2 million in 2025.
• Biggest YoY gain for Operating Leases was 33.6% in 2025; the steepest drop was 38.59% in 2025.
• A 5-year view of Operating Leases shows it stood at $14.9 million in 2022, then declined by 25.85% to $11.0 million in 2023, then decreased by 17.26% to $9.1 million in 2024, then soared by 33.6% to $12.2 million in 2025, then slipped by 19.2% to $9.8 million in 2026.
• The last three Operating Leases figures came in at $9.8 million (Q1 2026), $12.2 million (Q4 2025), and $7.6 million (Q3 2025), per Business Quant data.